TLX
Telix Pharms
Stock
Stock
ISIN: AU000000TLX2
Ticker: TLX
AU000000TLX2
TLX
Price
Precio
GRÁFICO POR
Precios
- Lapso de 1 día
- 15,28 US$15,57 US$
- Período de 52 semanas
- 6,712 US$8,38 US$
Información
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.
- Industrias
- Biotechnology
- Sector
- Sanidad
Identificador
- Número de Identificación Internacional de Valores (ISIN)
- AU000000TLX2
- Teletipo de bolsa (ticker) principal
- TLX